Galderma Sues Paddock Over Clobex ANDA

Law360, New York (January 9, 2009, 12:00 AM EST) -- Dermatology product maker Galderma SA has fired off a lawsuit against Paddock Laboratories Inc., accusing the generic-drug maker of infringing a patent related to Clobex, a treatment for psoriasis.

The complaint, filed Wednesday in the U.S. District Court for the Northern District of Texas, claims Paddock is attempting to bring to market a generic version of Clobex, flagrantly infringing Galderma’s rights as a licensee of the patent for the clobetasol propionate spray treatment.

Paddock has submitted an abbreviated new drug application to the U.S. Food and...
To view the full article, register now.